1 Results found
Companies public-health
06 January 2022
Pet molecular diagnostics firm, PetDx, received $62 million in a series B financing. The funding follows a series A financing of $10 million. The most recent financing was led by various venture...
Copyright © 2026 - All Rights Reserved ISSN 2768-198X
About Us Authors Contact Us Legal Notes Privacy Search